フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Al ...
Immupharma PLC 11 November 2022 11 November 2022 ImmuPharma PLC ("ImmuPharma" or the "Company") Avion confirms its continued...
Immupharma PLC 11 October 2022 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this...
Immupharma PLC 11 October 2022 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call...
Immupharma PLC 07 October 2022 07 October 2022 ImmuPharma PLC ("ImmuPharma" or the "Company") Appointment of Company Secretary...
Incanthera PLC 06 October 2022 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant...
Immupharma PLC 30 September 2022 30 September 2022 ImmuPharma PLC ("ImmuPharma" or the "Company") Lupuzor(TM) Update...
Immupharma PLC 30 September 2022 RNS: RELEASE | 30 SEPTEMBER 2022 ImmuPharma PLC ("ImmuPharma" or the "Company") INTERIM...
Immupharma PLC 29 September 2022 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this...
Immupharma PLC 29 September 2022 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call...
specialist drug discovery and development company - Says its US partner for Lupuzor, Avion Pharmaceuticals LLC, has re ...
Immupharma PLC 14 September 2022 14 September 2022 ImmuPharma PLC ("ImmuPharma" or the "Company") Written Response received...
specialist drug discovery and development company - Says L1 Capital Global Opportunities Master Fund has exercised opt ...
Immupharma PLC 07 September 2022 7 September 2022 ImmuPharma plc ("ImmuPharma" or the "Company") Exercise of Options...
Support
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す